Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Senti Biosciences Inc (NASDAQ: SNTI) closed at $1.04 in the last session, down -0.95% from day before closing price of $1.05. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 0.44 million shares were traded. SNTI stock price reached its highest trading level at $1.1 during the session, while it also had its lowest trading level at $1.04.
Ratios:
We take a closer look at SNTI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.51 and its Current Ratio is at 1.51. In the meantime, Its Debt-to-Equity ratio is 3.71 whereas as Long-Term Debt/Eq ratio is at 3.08.
Upgrades & Downgrades
. In the most recent recommendation for this company, H.C. Wainwright on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On June 06, 2025, Laidlaw started tracking the stock assigning a Buy rating and target price of $5.
On October 07, 2022, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $7.50.Morgan Stanley initiated its Equal-Weight rating on October 07, 2022, with a $7.50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Lu Timothy K sold 3,922 shares for $4.07 per share. The transaction valued at 15,963 led to the insider holds 82,627 shares of the business.
Lu Timothy K sold 545 shares of SNTI for $2,376 on Feb 06 ’25. The CEO now owns 82,082 shares after completing the transaction at $4.36 per share. On Feb 04 ’25, another insider, Rajangam Kanya, who serves as the Pres. & Chief Med. & Dev. Off. of the company, sold 1,297 shares for $4.07 each. As a result, the insider received 5,279 and left with 8,803 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNTI now has a Market Capitalization of 27342470 and an Enterprise Value of 44687472.
Stock Price History:
The Beta on a monthly basis for SNTI is 2.10, which has changed by -0.72440946 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, SNTI has reached a high of $5.10, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -40.41%, while the 200-Day Moving Average is calculated to be -53.96%.
Shares Statistics:
According to the various share statistics, SNTI traded on average about 1.59M shares per day over the past 3-months and 522140 shares per day over the past 10 days. A total of 26.29M shares are outstanding, with a floating share count of 6.79M. Insiders hold about 74.16% of the company’s shares, while institutions hold 6.98% stake in the company. Shares short for SNTI as of 1765756800 were 1663760 with a Short Ratio of 1.05, compared to 1763078400 on 177642. Therefore, it implies a Short% of Shares Outstanding of 1663760 and a Short% of Float of 6.38.
Earnings Estimates
As of right now, 3.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.53 and low estimates of -$0.53. Analysts are recommending an EPS of between -$2.02 and -$2.86 for the fiscal current year, implying an average EPS of -$2.56. EPS for the following year is -$1.39, with 3.0 analysts recommending between -$0.86 and -$1.91.
